
Pradeep Pa Mammen MD FACC, FAHA, FHFSA
Heart Failure & Transplantation, Cardiovascular Disease Genetics
Professor of Internal Medicine; Alfred W. Harris, MD Professorship in Cardiology; Co-Director: UTSW Wellstone Muscular Dystrophy Reseach Center; Medical Director: Neuromuscular Cardiomyopathy Clinic; Director: Translational Research for the Advanced Heart Failure &Transplant Cardiology Program; Member of the UTSW Heart Failure, Ventricular Assist Devices, & Heart Transplant Program.
Join to View Full Profile
4000 Cambridge StSte G600Kansas City, KS 66160
Phone+1 913-588-9600
Fax+1 214-648-1450
Dr. Mammen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a clinician-scientist with clinical expertise in advanced heart failure, ventricular assist devices and heart transplantation. From a clinical perspective, I am one of only approximately 1,000 adult cardiologists in the US board certified in advanced heart failure/heart transplantation. I am currently an Associate Professor of Medicine, Co-Director of the UTSW Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (one of six NIH funded Centers in the country), and the Director for Translational Research for the Advanced Heart Failure and Transplant Cardiology Program at UTSW. Finally, I have developed clinical expertise in the care of patients who develop a familial or genetic form of cardiomyopathy (esp. neuromuscular-associated cardiomyopathies). In 2010, I founded and became the Medical Director of the UTSW Neuromuscular Cardiomyopathy Clinic. This clinic is only one of six adult clinics in the United States exclusively dedicated to addressing the cardiovascular needs of patients with neuromuscular disorders.
In keeping with my clinical interest in the treatment and management of patients with heart failure, I have developed significant scientific expertise in investigating the molecular mechanisms underlying heart failure and cardiac/skeletal muscle myopathies. In the Fall of 2015, Dr. Eric Olson, Chair of the UTSW Department of Molecular Biology and I became the Co-Directors of the UTSW Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center. The core mission of the Center is to rapidly develop genome editing into a viable and effective therapy for patients with Duchenne muscular dystrophy. In addition, I run a NIH R01-funded molecular laboratory focused on mechanistic studies to enhance our understanding of various signaling pathways that contribute to heart failure and cardiac/skeletal muscle myopathies.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Advanced Heart Failure and Transplant Cardiology, 2003 - 2004
University of Texas Southwestern Medical CenterPost-Doctoral Fellowship, 2000 - 2004
University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1998 - 2000
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1995 - 1998
University of Wisconsin School of Medicine & Public HealthClass of 1995, MD, Outstanding Medical Student Research Award (1994), Outstanding Leadership and Service Award (1991)
University of PennsylvaniaB.S.E., Bioengineering/Electrical Engineering, 1987 - 1990
Certifications & Licensure
IA State Medical License 1995 - 2026
KS State Medical License 2023 - 2026
MO State Medical License 2023 - 2026
TX State Medical License 1998 - 2026
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- Co-Director: UTSW Wellstone Muscular Dystrophy Specialized Research Center NIH U54/P50 Research Grant: Co-Recipient with Eric N. Olson, PhD
- Heart Failure Society of America: Fellow Heart Failure Society of America, 2020
- Recipient of a NIH-NHLBI R01 Research Grant National Institute of Health (NHLBI), 2012-2019
- Join now to see all
Publications & Presentations
PubMed
- Letter by Araj and Mammen Regarding Article, "Disseminated Intracardiac Thrombosis Due to Long-Standing, Asymptomatic Ventricular Fibrillation Under Left Ventricular A...Faris G Araj, Pradeep P A Mammen
Circulation. Heart Failure. 2025-10-01 - Right atrial pressure torsades de pointes.Hadi Beaini, Alpesh A Amin, Pradeep P A Mammen, Faris G Araj
The Journal of Invasive Cardiology. 2024-01-01 - 18 citationsA humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing.Yu Zhang, Hui Li, Takahiko Nishiyama, John R McAnally, Efrain Sanchez-Ortiz
Molecular Therapy. Nucleic Acids. 2022-09-13
Lectures
- Management of Duchenne muscular dystrophy-associated cardiomyopathy.Action Duchenne International Conference-2015 (London, UK) - 11/6/2015
- Circulating microRNAs in cardiomyopathyCareDx Inc. (San Francisco, CA) - 10/26/2015
- Development of atrophic cardiomyopathy in neuromuscular disorders: A novel mode of maladaptive cardiac remodeling.Senator Paul D. Wellstone Muscular Dystrophy Center Network Conference (U. of Washington-Seattle) - 10/14/2015
- Join now to see all
Authored Content
- The nuclear envelope protein Net39 is essential for muscle nuclear integrity and chromatin organizationJanuary 2021
Press Mentions
First Cardiovascular Gene Therapy Trial in U.S. For People with Duchenne Muscular Dystrophy Begins at KU Medical CenterJuly 18th, 2025
Dosing Begins in Gene Therapy Trial for DMD-Linked Heart DiseaseJuly 17th, 2025
Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated CardiomyopathyJuly 15th, 2025- Join now to see all
Grant Support
- Development of early metabolic imaging biomarkers for muscular dystrophy and cardiomyopathy in patientsUT SOUTHWESTERN MEDICAL CENTER2024–2028
- Myoediting of Duchenne Muscular DystrophyUT SOUTHWESTERN MEDICAL CENTER2015–2025
- Cytoglobin: A Stress-Responsive Hemoprotein Modulating Cardiomyocyte SurvivalNational Heart, Lung, And Blood Institute2012
- Regulation of tissue hemoglobins in the heart.National Institute of Health (K08 Research Grant; NHLBI)2005–2011
- Regulation Of Tissue Hemoglobins In The HeartNational Heart, Lung, And Blood Institute2005–2009
Professional Memberships
- Member
- Fellow
- Fellow
- American Society for Biochemistry and Molecular BiologyMember
- Central Society for Clinical and Translational ResearchMember
- Dallas County Medical SocietyMember
- Heart Failure Society of AmericaFellow
- International Society of Heart and Lung TransplantationMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









